Cargando…
Cox Models Survival Analysis Based on Breast Cancer Treatments
BACKGROUND: The aim of this study is to evaluate the association between different treatments and survival time of breast cancer patients using either standard Cox model or stratified Cox model. METHODS: The study was conducted on 15830 women diagnosed with breast cancer in British Columbia, Canada....
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Research Center, Shahid Beheshti University of Medical Sciences
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171826/ https://www.ncbi.nlm.nih.gov/pubmed/25250162 |
_version_ | 1782335955379683328 |
---|---|
author | Abadi, Alireza Yavari, Parvin Dehghani-Arani, Monireh Alavi-Majd, Hamid Ghasemi, Erfan Amanpour, Farzaneh Bajdik, Chris |
author_facet | Abadi, Alireza Yavari, Parvin Dehghani-Arani, Monireh Alavi-Majd, Hamid Ghasemi, Erfan Amanpour, Farzaneh Bajdik, Chris |
author_sort | Abadi, Alireza |
collection | PubMed |
description | BACKGROUND: The aim of this study is to evaluate the association between different treatments and survival time of breast cancer patients using either standard Cox model or stratified Cox model. METHODS: The study was conducted on 15830 women diagnosed with breast cancer in British Columbia, Canada. They were divided into eight groups according to patients’ ages and stage of disease Either Cox’s PH model or stratified Cox model was fitted to each group according to the PH assumption and tested using Schoenfeld residuals. RESULTS: The data show that in the group of patients under age 50 years old and over age 50 with stage I cancer, the highest hazard was related to radiotherapy (HR= 3.15, CI: 1.85-5.35) and chemotherapy (HR= 3, CI: 2.29- 3.93) respectively. For both groups of patients with stage II cancer, the highest risk was related to radiotherapy (HR=3.02, CI: 2.26-4.03) (HR=2.16, CI:1.85-2.52). For both groups of patients with stage III cancer, the highest risk was for surgery (HR=0.49, CI: 0.33-0.73), (HR=0.45, CI: 0.36-0.57). For patients of age 50 years or less with stage IV cancer, none of the treatments were statistically significant. In group of patients over age 50 years old with stage IV cancer, the highest hazard was related to surgery (HR=0.64, CI: 0.53-0.78). CONCLUSION: The results of this study show that for patients with stage I and II breast cancer, radiotherapy and chemotherapy had the highest hazard; for patients with stage III and IV breast cancer, the highest hazard was associated with treatment surgery. |
format | Online Article Text |
id | pubmed-4171826 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Cancer Research Center, Shahid Beheshti University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-41718262014-09-23 Cox Models Survival Analysis Based on Breast Cancer Treatments Abadi, Alireza Yavari, Parvin Dehghani-Arani, Monireh Alavi-Majd, Hamid Ghasemi, Erfan Amanpour, Farzaneh Bajdik, Chris Iran J Cancer Prev Original Article BACKGROUND: The aim of this study is to evaluate the association between different treatments and survival time of breast cancer patients using either standard Cox model or stratified Cox model. METHODS: The study was conducted on 15830 women diagnosed with breast cancer in British Columbia, Canada. They were divided into eight groups according to patients’ ages and stage of disease Either Cox’s PH model or stratified Cox model was fitted to each group according to the PH assumption and tested using Schoenfeld residuals. RESULTS: The data show that in the group of patients under age 50 years old and over age 50 with stage I cancer, the highest hazard was related to radiotherapy (HR= 3.15, CI: 1.85-5.35) and chemotherapy (HR= 3, CI: 2.29- 3.93) respectively. For both groups of patients with stage II cancer, the highest risk was related to radiotherapy (HR=3.02, CI: 2.26-4.03) (HR=2.16, CI:1.85-2.52). For both groups of patients with stage III cancer, the highest risk was for surgery (HR=0.49, CI: 0.33-0.73), (HR=0.45, CI: 0.36-0.57). For patients of age 50 years or less with stage IV cancer, none of the treatments were statistically significant. In group of patients over age 50 years old with stage IV cancer, the highest hazard was related to surgery (HR=0.64, CI: 0.53-0.78). CONCLUSION: The results of this study show that for patients with stage I and II breast cancer, radiotherapy and chemotherapy had the highest hazard; for patients with stage III and IV breast cancer, the highest hazard was associated with treatment surgery. Cancer Research Center, Shahid Beheshti University of Medical Sciences 2014 /pmc/articles/PMC4171826/ /pubmed/25250162 Text en © 2014 Cancer Research Center, Shahid Beheshti University of Medical Sciences http://creativecommons.org/licenses/by-nc/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly. |
spellingShingle | Original Article Abadi, Alireza Yavari, Parvin Dehghani-Arani, Monireh Alavi-Majd, Hamid Ghasemi, Erfan Amanpour, Farzaneh Bajdik, Chris Cox Models Survival Analysis Based on Breast Cancer Treatments |
title | Cox Models Survival Analysis Based on Breast Cancer Treatments |
title_full | Cox Models Survival Analysis Based on Breast Cancer Treatments |
title_fullStr | Cox Models Survival Analysis Based on Breast Cancer Treatments |
title_full_unstemmed | Cox Models Survival Analysis Based on Breast Cancer Treatments |
title_short | Cox Models Survival Analysis Based on Breast Cancer Treatments |
title_sort | cox models survival analysis based on breast cancer treatments |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171826/ https://www.ncbi.nlm.nih.gov/pubmed/25250162 |
work_keys_str_mv | AT abadialireza coxmodelssurvivalanalysisbasedonbreastcancertreatments AT yavariparvin coxmodelssurvivalanalysisbasedonbreastcancertreatments AT dehghaniaranimonireh coxmodelssurvivalanalysisbasedonbreastcancertreatments AT alavimajdhamid coxmodelssurvivalanalysisbasedonbreastcancertreatments AT ghasemierfan coxmodelssurvivalanalysisbasedonbreastcancertreatments AT amanpourfarzaneh coxmodelssurvivalanalysisbasedonbreastcancertreatments AT bajdikchris coxmodelssurvivalanalysisbasedonbreastcancertreatments |